Business

Hinge Health reports record first quarter 2026 financial results

SAN FRANCISCO, May 05, 2026--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026.

articleHinge Health, Inc.May 5, 202620/company/hinge-health-inc/news/hinge-health-reports-record-first-quarter-2026-financial-results
Hinge Health reports record first quarter 2026 financial results

About this update from Hinge Health, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":283,"url":"https://media.zenfs.com/en/business-wire.com/49e23ab5740f608f3f61d97c91343aa6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QIjz1UOIklFcgzb0z_1kEA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU2Ng--/https://media.zenfs.com/en/business-wire.com/49e23ab5740f608f3f61d97c91343aa6","width":480,"height":283}},"lazy":false},{"type":"text","content":"SAN FRANCISCO, May 05, 2026--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026.","length":155,"tagName":"p"},{"type":"text","content":""We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs," said Daniel Perez, Co-Founder and CEO, Hinge Health. "Based on this momentum, we’re raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn’t build this company to stop at digital physical therapy; we built it to transform how healthcare is delivered at scale."","length":704,"tagName":"p"},{"type":"text","content":"First Quarter Financial Highlights:","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue increased 47% year-over-year to $182.3 million compared to revenue of $123.8 million in Q1 2025.","length":104,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GAAP and Non-GAAP gross margin were 85% compared to 81% in Q1 2025.","length":67,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GAAP income from operations increased 144% to $32.1 million compared to GAAP income from operations of $13.1 million in Q1 2025. Non-GAAP income from operations increased 208% to $46.2 million compared to non-GAAP income from operations of $15.0 million in Q1 2025.","length":265,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GAAP diluted net income per share was $0.41. Non-GAAP diluted net income per share was $0.45.","length":93,...

More updates from Hinge Health, Inc.

operating marginFree cash flowincome from operationsstock-based compensationFree cash flowGAAPoperating marginStock-based compensationNet income attributableGAAP income from operations